AXT (NASDAQ:AXTI) Director Jesse Chen Sells 8,800 Shares of Stock

AXT Inc (NASDAQ:AXTI) Director Jesse Chen sold 8,800 shares of AXT stock in a transaction on Wednesday, March 4th. The shares were sold at an average price of $38.83, for a total transaction of $341,704.00. Following the completion of the sale, the director owned 178,211 shares in the company, valued at approximately $6,919,933.13. This trade represents a 4.71% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website.

Jesse Chen also recently made the following trade(s):

• On Thursday, March 5th, Jesse Chen sold 11,147 shares of AXT stock. The stock was sold at an average price of $38.26, for a total transaction of $426,484.22.
• On Tuesday, March 3rd, Jesse Chen sold 11,007 shares of AXT stock. The shares were sold at an average price of $40.49, for a total transaction of $445,673.43.
• On Monday, March 2nd, Jesse Chen sold 11,320 shares of AXT stock. The shares were sold at an average price of $45.59, for a total transaction of $516,078.80.

AXT Price Performance

AXTI stock traded down $2.42 during trading on Friday, reaching $36.37. The company had a trading volume of 4,215,610 shares, compared to its average volume of 8,074,994. AXT Inc has a 52 week low of $1.13 and a 52 week high of $47.03. The company has a market cap of $2.01 billion, a P/E ratio of -75.77 and a beta of 1.75. The business has a 50 day moving average of $24.12 and a 200 day moving average of $13.19.

AXT (NASDAQ:AXTI) last posted its quarterly earnings data on Thursday, February 19th. The semiconductor company reported ($0.05) earnings per share for the quarter, missing the consensus estimate of ($0.04) by ($0.01). AXT had a negative net margin of 24.07% and a negative return on equity of 10.59%. The firm had revenue of $23.04 million for the quarter, compared to the consensus estimate of $24.24 million. Research analysts expect that AXT Inc will post -0.12 earnings per share for the current year.

Wall Street Analyst Weigh In

Several brokerages have commented on AXTI. Wedbush raised their price objective on AXT from $8.50 to $28.00 and gave the company an “outperform” rating in a research report on Friday, February 20th. Northland Securities set a $20.00 price target on shares of AXT in a research note on Monday, December 22nd. UBS Group set a $35.00 price target on shares of AXT in a research report on Tuesday, February 17th. Craig Hallum restated a “buy” rating on shares of AXT in a report on Friday, January 9th. Finally, Wall Street Zen upgraded shares of AXT from a “sell” rating to a “hold” rating in a report on Saturday, February 14th. Two investment analysts have rated the stock with a Buy rating, two have assigned a Hold rating and one has issued a Sell rating to the company’s stock. Based on data from MarketBeat.com, the stock presently has an average rating of “Hold” and a consensus target price of $22.80.

Institutional Trading of AXT

Several institutional investors have recently bought and sold shares of AXTI. XTX Topco Ltd bought a new stake in AXT during the 2nd quarter valued at about $42,000. Jefferies Financial Group Inc. purchased a new stake in shares of AXT during the third quarter valued at approximately $52,000. State of Wyoming purchased a new stake in shares of AXT during the fourth quarter valued at approximately $69,000. Creative Planning bought a new stake in shares of AXT during the second quarter valued at approximately $86,000. Finally, Kestra Advisory Services LLC purchased a new position in AXT in the 4th quarter worth approximately $98,000. 49.52% of the stock is owned by hedge funds and other institutional investors.

AXT News Summary

Here are the key news stories impacting AXT this week:

• Positive Sentiment: Large institutional buyers added or established meaningful Q4 positions (e.g., Davidson Kempner, Point72, Jane Street, CloudAlpha, Alyeska, Maytree), which can supply underlying demand and support the stock over time.
• Positive Sentiment: Recent bullish commentary highlights AXT as a play on compound‑semiconductor substrates (GaAs/InP/GaN), which may attract sector investors chasing secular demand in RF/wireless and optoelectronics. Read More.
• Neutral Sentiment: Analyst coverage is mixed (buy/hold/sell split) and the consensus price target sits below recent trading, so analyst action is unlikely to be an immediate directional catalyst.
• Neutral Sentiment: Reported short‑interest data in public feeds is inconsistent/zero, so there’s no clear short‑squeeze or mounting short pressure explaining today’s move.
• Negative Sentiment: Significant insider selling this week: CEO Morris Young sold 159,536 shares (~$6.9M at reported averages) and directors Jesse Chen and David C. Chang sold sizable blocks — a strong near‑term negative signal that likely increased selling pressure. Read More.
• Negative Sentiment: Q4 FY2025 results: revenue (~$23.0M) and EPS (miss) kept the company unprofitable and produced negative margins — fundamentals that justify caution until revenue/profitability trends improve. Read More.
• Negative Sentiment: Net insider activity in recent weeks is heavily skewed to selling with few reported insider buys, which is a governance/sentiment headwind that often triggers short‑term outflows. Read More.

AXT Company Profile

AXT, Inc (NASDAQ: AXTI) is a global supplier of compound and single-element semiconductor substrates, offering a range of materials critical for high-performance electronic and optoelectronic devices. Founded in 1986 and headquartered in Fremont, California, AXT specializes in the development, manufacture and distribution of wafers composed of gallium arsenide (GaAs), indium phosphide (InP), gallium nitride (GaN) and other compound semiconductor materials. These substrates serve as the foundational platforms for devices used in data communications, wireless infrastructure, advanced computing, consumer electronics and photovoltaic applications.

AXT’s product portfolio encompasses a variety of wafer sizes, dopant concentrations and crystal orientations, tailored to meet the precise specifications of its customers.